RxDoctor Payments Data

Ashley Munn

Family · Manchester, KYNPI 1003243858

Payments from drug & device makers

$2,447in general payments, 2019–2025

Across 139 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$731
  • AstraZeneca$307
  • Novo Nordisk$300
  • GSK$118
  • Bayer$114
  • Dexcom, Inc.$101
  • plus $775 from 17 others

What the payments were for

  • Food & beverage$2,447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,447 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$58,205
OzempicSemaglutide54$57,895
MounjaroTirzepatide50$54,259
JanuviaSitagliptin Phosphate69$42,763
JardianceEmpagliflozin53$35,188
LinzessLinaclotide47$25,976
Spiriva RespimatTiotropium Bromide48$25,776
FarxigaDapagliflozin Propanediol34$22,888
Ondansetron Hcl89$22,171
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$20,547
TradjentaLinagliptin38$19,318
VraylarCariprazine Hcl12$17,286
Tresiba Flextouch U-200Insulin Degludec11$14,741
Tresiba Flextouch U-100Insulin Degludec21$11,329
Albuterol Sulfate HfaAlbuterol Sulfate290$9,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$13$80,282139 claims
PfizerEliquis$83$58,20576 claims
Novo NordiskOzempic$300$57,89554 claims
Lilly USA, LLCMounjaro$74$54,25950 claims
AbbVieLinzess, Vraylar, Synthroid$731$44,24075 claims
MerckJanuvia$82$42,76369 claims
AstraZenecaFarxiga, Symbicort$307$25,39746 claims
GSKTrelegy Ellipta$118$20,54720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Manchester

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →